跳至主要内容
临床试验/NCT05982119
NCT05982119招募中不适用

Gait Analysis Parameter, Stair Climbing and Upper Limb Evaluation in Patients With Muscular Pathology and in Control Subjects: The ActiLiège Next Study

Centre Hospitalier Universitaire de Liege11 个研究点 分布在 7 个国家目标入组 300 人开始时间: 2020年7月10日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
300
试验地点
11
主要终点
Stride velocity

研究概览

简要总结

The objective of the ActiLiège Next study is to collect longitudinal data from patients and control subjects using a wearable magneto-inertial device. By collecting natural history data in various neuromuscular disorders (Duchenne Muscular Dystrophy, Fascioscapulohumeral Muscular Dystrophy, Myotonic Dystrophy 1, Charcot-Marie-Tooth, Centronuclear Myopathy, Congenital Muscular Dystrophy), we aim to validate digital outcome measures to continuously assess motor function in real-life.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
1 Year 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • For the patients:
  • Patients with extreme cognitive disorders that limit their understanding of the exercises to be performed.
  • Patients who have undergone a surgical procedure or who have experienced recent trauma (within fewer than 6 months) affecting the upper or lower limbs (for ambulant patients).
  • A concomitant chronic or acute neurological, endocrine, infectious, allergic, or inflammatory pathology within the 3-week period immediately prior to inclusion.
  • Patients who are participating in an interventional clinical trial.
  • DMD patients in transition who are not on corticosteroids.
  • For the control subjects:
  • Patients who have undergone a surgical procedure or who have experienced recent trauma (within fewer than 6 months) affecting the upper or lower limbs.
  • Elite athletes (at the national level).
  • A chronic or acute muscular, neurological, infectious, or inflammatory pathology within the 3-week period immediately prior to inclusion.
  • An orthopedic, neuromuscular, or neurological pathology that affects the quality of the subject's walking gait.

结局指标

主要结局

Stride velocity

时间窗: through study completion (3 year)

Stride velocity obtained with a magneto-inertial sensor (Actimyo°) in real-life (meter per second).

Stride length

时间窗: through study completion (3 year)

Stride length obtained with a magneto-inertial sensor (Actimyo°) in real-life (meter).

Stairs height

时间窗: through study completion (3 year)

Height of the strides in stairs obtained with a magneto-inertial sensor (Actimyo°) in real-life

Stairs speed

时间窗: through study completion (3 year)

Vertical speed during strides in stairs obtained with a magneto-inertial sensor (Actimyo°) in real-life

Stairs number

时间窗: through study completion (3 year)

Total number of strides in stairs obtained with a magneto-inertial sensor (Actimyo°) in real-life

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Laurent Servais

Professor Laurent Servais

Centre Hospitalier Universitaire de Liege

研究点 (11)

Loading locations...

相似试验